These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 631971)
41. Clinical evaluation of vascoray. (Sodium iothalamate 26 percent-methylglucamine iothalamate 52 per cent--a new contrast medium. Marshall TR Angiology; 1973 May; 24(5):288-96. PubMed ID: 4707981 [No Abstract] [Full Text] [Related]
42. Solute excretion during intravenous urography. A comparison of sodium iothalamate and sodium iocarmate (iothalamate dimer). Evill CA; Benness GT Invest Radiol; 1975; 10(6):552-6. PubMed ID: 1201936 [TBL] [Abstract][Full Text] [Related]
43. Absorption of iothalamate after oral administration: a preliminary study in humans and interspecies differences. Prueksaritanont T; Chiou WL Biopharm Drug Dispos; 1987; 8(1):99-101. PubMed ID: 3580517 [No Abstract] [Full Text] [Related]
45. [The effect of renal function on the elimination of contrast medium by infusion pyelography]. Bahlmann J; Gollnisch HJ; Krüskemper HL Eur J Clin Pharmacol; 1972 Jun; 4(3):162-9. PubMed ID: 4655291 [No Abstract] [Full Text] [Related]
46. Apparent volumes of distribution of 125-I-lothalamate and inulin in chickens. Harris KM; Koike TI Proc Soc Exp Biol Med; 1975 May; 149(1):242-7. PubMed ID: 1170565 [TBL] [Abstract][Full Text] [Related]
47. [A new contrast medium for urography (Uromiron)]. de Barros J Hospital (Rio J); 1967 Dec; 72(6):1793-5. PubMed ID: 5308473 [No Abstract] [Full Text] [Related]
48. Gallbladder seen on excretory urography: a case report. Arkless R J Urol; 1969 Dec; 102(6):765-7. PubMed ID: 5372033 [No Abstract] [Full Text] [Related]
49. A new angiographic contrast medium, sodium iothalamate 80 percent. A clinical and experimental evaluation. FOSTER JH; WINFREY EW; KILLEN DA; SESSIONS RT JAMA; 1962 Dec; 182():1009-13. PubMed ID: 13958902 [No Abstract] [Full Text] [Related]
50. [Ionized plasma calcium variations and injection of radiologic contrast media]. Glomaud D; Salamagne JC; Dauchy F; Tonnelier M; Ngwing Tin L; Malapel D Ann Fr Anesth Reanim; 1982; 1(3):297-300. PubMed ID: 7165144 [TBL] [Abstract][Full Text] [Related]
51. Extensive local necrosis following the intravenous use of X-ray contrast medium in the upper extremity. Leung PC; Cheng CY Br J Radiol; 1980 Apr; 53(628):361-4. PubMed ID: 7378706 [No Abstract] [Full Text] [Related]
52. Urography with the iothalamate dimer and trimer. Benness GT Australas Radiol; 1970 Nov; 14(4):416-8. PubMed ID: 5498300 [No Abstract] [Full Text] [Related]
53. An overview of the clinical pharmacokinetics of x-ray contrast media. Bourin M; Jolliet P; Ballereau F Clin Pharmacokinet; 1997 Mar; 32(3):180-93. PubMed ID: 9084958 [TBL] [Abstract][Full Text] [Related]
54. [Sodium salts or methylglucamine salts in contrast media for infusion pyelography? (author's transl)]. Taenzer V; Albrecht A; Clauss W; Held I Radiologe; 1981 Jun; 21(6):288-90. PubMed ID: 7022552 [TBL] [Abstract][Full Text] [Related]
55. Double blind comparison of ioglicate and iothalamate in intravenous urography. Baitsch T; Beduhn D; Klink G Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():143-7. PubMed ID: 6139069 [No Abstract] [Full Text] [Related]
56. [Cerebral angiography with ioglicinate (Rayvist). A double blind study of image quality and clinical side effects (author's transl)]. Stoeter P; Voigt K Radiologe; 1979 Nov; 19(11):494-8. PubMed ID: 388513 [TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications. Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016 [TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics and clinical studies of ioglicinate, a new contrast medium for intravenous urography. Nagel R; Leistenschneider W; Speck U; Clauss W Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):49-53. PubMed ID: 631971 [TBL] [Abstract][Full Text] [Related]